Six‐week infusion of Ang‐II into WT and TNFR1‐KO mice resulted in the same degree of hypertension and cardiac dysfunction; by contrast, cardiac hypertrophy and remodeling remained lower in TNFR1‐KO. The gene discussed is TNFRSF1A; the disease is cardiac hypertrophy.